AHRNYSEReal Estate Investment TrustsFiscal year ends December 31

American Healthcare REIT, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$52.45−0.78 (-1.47%)

Close on Oct 19, 2026

Market cap: $10.14B
P/E (TTM): 77.1
Dividend yield: 1.91%

American Healthcare REIT, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31
Revenue	2,260	2,071	1,867	1,412	1,124	1,069	1,099	84	33	3.16
Cost of Revenue	1,794	1,654	1,502	1,282	1,030	994	968	30	7.29	0.90
Gross Profit	467	417	364	131	94	75	131	54	26	2.26
General & Administrative	59	48	48	43	43	27	30	9.17	4.34	1.22
Operating Expenses	–	–	–	–	–	–	–	–	–	0.44
Total Costs & Expenses	2,096	1,941	1,796	1,557	1,258	1,152	1,143	86	30	8.12
Operating Income	415	364	307	302	213	218	221	–	–	-4.96
Interest Expense	86	128	163	106	81	71	79	6.79	2.70	0.51
Income from Equity Investments	-1.97	-6.87	-1.72	1.41	-1.36	-4.52	-2.10	-0.11	0	0
Other Non-Operating Income	-115	-164	-147	-159	-76	-86	-80	–	–	–
Merger & Restructuring Charges	5.10	7.14	5.80	–	–	–	–	–	–	–
Asset Impairment Charges	–	0	11	23	0	0	0	–	–	–
Pretax Income	49	-34	-76	-73	-52	5.79	0.67	-8.58	0.51	-5.47
Income Tax Expense	-22	1.71	0.66	0.59	0.96	-3.08	1.52	0.01	0	0
Net Income incl. Noncontrolling Interests	71	-36	-77	-73	-53	8.86	-0.85	-8.59	0.51	-5.47
Minority Interest in Earnings	1.01	2.21	-5.42	7.92	-5.48	6.70	4.11	-0.23	–	–
Net Income	70	-38	-71	-81	-48	2.16	-4.97	-8.35	0.54	-5.47
EPS (Basic)(per share)	0.42	-0.29	-1.08	-1.24	-0.95	0.05	-0.12	-0.26	0.03	-3.00
EPS (Diluted)(per share)	0.42	-0.29	-1.08	-1.24	-0.95	0.05	-0.12	-0.26	0.03	-3.00
Shares Outstanding (Basic, Weighted)(shares)	166	131	66	66	50	45	45	32	16	1.83
Shares Outstanding (Diluted, Weighted)(shares)	167	131	66	66	50	45	45	32	16	1.83
Dividend per Share(per share)	1.00	1.00	1.00	1.60	0.69	0.86	2.60	1.03	1.03	0.69
EBITDA	603	543	489	470	347	317	333	–	–	-3.71

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 21.2%
Operating margin: 19.2%
Net margin: 4.8%
Return on equity, FY2025: 2.5%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: 77.1
Price to sales: 4.05
Price to book: 2.74
Dividend yield: 1.91%